Feedback
BD Club Max
Login ×
BD molecular workflow specialist team helping lab technician with their BD MAX™ molecular workflow.
BD MAX™ System - March 20, 2023

Introducing: Molecular Workflow Optimisation Service for the BD MAX™ System

Add to fav remove to fav Add to favorites Thumb up remove thumb up Like the content

An optimised lab is supported by automation, workflow and people. However, successful optimisation requires time, knowledge and experience.

With our new BD MAX™ Laboratory Optimisation and Capacity Assessment, our BD expert team can help you optimise your lab’s molecular processes, from lab organisation, resource availability and overall efficiency.

Across the molecular sample pathway, work hands-on with our molecular workflow experts to optimise the use of your BD MAX™ System and its associated processes. Our offering is tailored to your goals, focusing on the following key areas:

  • Efficiency: hands-on time, time to result
  • Productivity: Peak day demand, resource allocation
  • Quality: Percentage of contamination, repeat rates
  • Process flow: Lab layout, testing algorithms

To gain a deeper understanding of your current challenges and curate a solution that is right for you, the assessment is conducted in three phases:

  1. Observe: On-site observation and Laboratory Optimisation and Capacity (LOC) assessment to evaluate molecular workflow, LIS integration, lab floor plan and current testing algorithms
  2. Design: Follow-up meeting to present personalised recommendations based on your key performance indicators (KPIs) to improve workflow, resource utilisation, staff efficiency and testing capacity
  3. Collaborate: Continuous partnership in implementing new processes for an improved molecular workflow that meets your changing needs

Learn more about the Molecular Workflow Optimisation Service and get on the path to an optimised BD MAX™ System workflow:

Molecular Workflow Optimisation Service for the BD MAX™ System

Login to download
By reading this content you are acknowledging our forward looking statement.

Why join BD MAX™ Club?

Connect with professionals from around the world BD MAX™ Club members represent a community of professionals in infectious diseases and molecular diagnostics. With regional meet-ups and live webinars from global experts, expand your laboratory’s network and collaborate with worldwide colleagues.

Tailored medical and technical expertise Whether you need compelling scientific research or tutorials for troubleshooting on the BD MAX™ System, BD MAX™ Club is here to accompany your molecular diagnostics journey. Log in to your BD MAX™ Club account anywhere, anytime to access our information database.

Exclusive members’ perks BD MAX™ Club membership unlocks doors to exclusive webinars and collaboration with industry leading experts. Engage with your colleagues in the molecular community and exchange with the BD research and development team.

Join BD MAX™ Club

Latest news

How can BD MAX™ Club support your lab’s challenges?

All topics

Forward Looking Statement

The information included on this website and other information provided from time to time through webcasts, conference calls, securities analyst meetings, road show presentations, investor conferences, newsletters and similar events and communications contains forward-looking statements (as defined under Federal securities laws) based on current expectations and assumptions that involve risks and uncertainties. If the risks or uncertainties ever materialize or the assumptions prove incorrect, the results of BD may differ materially from those expressed or implied by such forward-looking statements and assumptions. Forward-looking statements may be identified by the use of words such as “plan,” “expect,” “believe,” “intend,” “will,” “may,” “anticipate,” “estimate” and other words of similar meaning in conjunction with, among other things, discussions of future operations and financial performance (including volume growth, pricing, sales and earnings per share growth, and cash flows) and statements regarding our strategy for growth, future product development, regulatory approvals, competitive position and expenditures.

All such statements are based upon current expectations of BD and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. Many of these risks and uncertainties are beyond the company’s control. For a discussion of certain factors that could cause our actual results to differ from our expectations in any forward-looking statements see our latest Annual Report on Form 10-K and other filings with the SEC. BD expressly disclaims any undertaking to update or revise any forward looking statements set forth herein to reflect events or circumstances after the date hereof, except as required by applicable law or regulation.